News Domain Therapeutics and Chime Biologics announce manufacturing agreement  to advance novel anti-CCR8

in tuning the hydropathy of class A GPCRs Arylsulfatases and neuraminidases modulate engagement of CCR5

awarded Hospital-University Research in Health (RHU) SPRINT consortium grant to progress its proprietary CCR8

Structural and Molecular Insights into GPCR Function Predicted Three-Dimensional Structure of the GCR1

for the cleavage of the porcine embryo by regulating HSP90 and the AKT pathway Structural basis for CCR6

GPCR Activation and Signaling The dual-function chemokine receptor CCR2 drives migration and chemokine

specific agonists Discovery of the Clinical Candidate IDOR-1117-2520: A Potent and Selective Antagonist of CCR6